Form 4: Charles River Laboratories Executive VP Sells Shares
SEC Form 4 Filing
Joseph W. LaPlume, EVP at Charles River Laboratories, sold 1,304 shares of common stock on May 10, 2024.
Summary
- On May 10, 2024, Joseph W. LaPlume, Executive Vice President, Corp Strategy & Develop at Charles River Laboratories International, Inc., sold 1,304 shares of common stock.
- The sale price was $226.97 per share.
- Following the transaction, LaPlume directly owns 23,276 shares of Charles River Laboratories common stock.
Sentiment
Score: 5
Explanation: Form 4 filings are neutral events. The sale itself doesn't necessarily indicate a negative outlook, as executives may sell shares for various personal financial reasons.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The sale of shares by an executive could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the transaction.
Key Dates
| Date | Description |
|---|---|
| 05/10/2024 | Date of stock sale transaction |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.